Contineum Therapeutics, Inc.
CTNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855175
In the last 90 days, Contineum Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $500.6M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in Contineum Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- +14 vs. Q1 2026
- Shares held
- 30.5M
- +2.73M (+9.8%) vs. Q1 2026
- Total value
- $500.6M
- +$137.2M (+37.8%) vs. Q1 2026
- New holders
- 29
- 32 more added
- Sold out
- 15
- 19 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTNM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 102 | $500.6M |
| Q1 2026 | 90 | $398.9M |
| Q4 2025 | 80 | $338.3M |
| Q3 2025 | 62 | $205.7M |
| Q2 2025 | 70 | $55.4M |
| Q1 2025 | 63 | $106.7M |
| Q4 2024 | 62 | $231.1M |
| Q3 2024 | 52 | $258.4M |
| Q2 2024 | 49 | $229.2M |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Contineum Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 2,734,836 | $44.8M | 0.02% | +2,734,836 | New |
| Suvretta Capital Management, LLC | 2,841,334 | $46.6M | 0.98% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −1,420,838−100.0% | Sold out |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,296,012−100.0% | Sold out |
| Jones Hill Capital LP | 0 | $0 | 0.00% | −513,053−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −107,380−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −55,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −54,068−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −42,818−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −42,178−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −22,984−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −22,170−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −14,200−100.0% | Sold out |
| Cannon Global Investment Management, LLC | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −12,799−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −12,382−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −10,729−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |